Shots:
- Myriad Genetics has commercially launched FirstGene Multiple Prenatal Screen, combining four prenatal genetic screens in a single blood draw as early as 8wks. gestation
- FirstGene covers common chromosomal conditions, 19 recessive fetal conditions, 20 maternal carrier conditions, & fetal RhD status, with >98% analytical sensitivity & >99% specificity, and results available in ~10 days; analytical validation was published in Clinical Chemistry
- The test is designed to streamline prenatal screening by combining multiple guideline-supported modalities into one order & report without requiring a reproductive partner sample
Ref: Globenewswire | Image: Myriad Genetics | Press Release
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
